It is still a low OS equity even with preferred shares converted. Read yesterday earnings report. That is what drove in the buyers. Absolutely stellar 10-Q. This stock is gradually on its way back to $25. share from a few years ago. You won't be trapped long. This stock is on its way up. Working with a huge pharma now as well. >>GROWING REVENUES.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.